Enhanced cytotoxic effect of radiation and temozolomide in malignant glioma cells: targeting PI3K-AKT-mTOR signaling, HSP90 and histone deacetylases

Por Choi, Eun Jung, Cho, Bong Jun, Lee, David J, Hwang, Yeo Hyeon, Chun, Sun Ha, Kim, Hans H, Kim, In Ah
Publicado em 2014

Analysis of phosphotyrosine signaling in glioblastoma identifies STAT5 as a novel downstream target of ΔEGFR

Por Chumbalkar, Vaibhav, Latha, Khatri, Hwang, YeoHyeon, Maywald, Rebecca, Hawley, Lauren, Sawaya, Raymond, Diao, Lixia, Baggerly, Keith, Cavenee, Webster K., Furnari, Frank B., Bogler, Oliver
Publicado em 2011

Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter

Por Latha, Khatri, Li, Ming, Chumbalkar, Vaibhav, Gururaj, Anupama, Hwang, YeoHyeon, Dakeng, Sumana, Sawaya, Raymond, Aldape, Kenneth, Cavenee, Webster K., Bogler, Oliver, Furnari, Frank B.
Publicado em 2012

Combined action of the dinuclear platinum compound BBR3610 with the PI3-K inhibitor PX-866 in glioblastoma

Por Gwak, Ho-Shin, Shingu, Takashi, Chumbalkar, Vaibhav, Hwang, Yeo-Hyeon, DeJournett, Robert, Latha, Khatri, Koul, Dimpy, Yung, W.K. Alfred, Powis, Garth, Farrell, Nicholas P., Bögler, Oliver
Publicado em 2011